The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 7 March 2005. doi:10.1084/jem.20041058
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 5, 675-680
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1812K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urbani, S.
Right arrow Articles by Ferrari, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urbani, S.
Right arrow Articles by Ferrari, C.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

Heterologous T cell immunity in severe hepatitis C virus infection

Simona Urbani1, Barbara Amadei1, Paola Fisicaro1, Massimo Pilli1, Gabriele Missale1, Antonio Bertoletti2,3, and Carlo Ferrari1

1 Laboratory of Viral Immunopathology, Department of Infectious Diseases and Hepatology, Azienda Ospedaliera Universitaria di Parma, Parma 43100, Italy
2 Institute of Hepatology, University College of London, London WC1E 6HX, UK
3 Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, 00149 Rome, Italy

CORRESPONDENCE Carlo Ferrari: cafer{at}tin.it

Hepatitis C virus (HCV) can cause liver disease of variable severity. Expansion of preexisting memory CD8 T cells by cross-reactivity with a new heterologous virus infection has been shown in mice to shape the repertoire of the primary response and to influence virus-related immunopathology (Selin, L.K. 2004. Immunity. 20:5–16). To determine whether this mechanism can influence the course of HCV infection, we analyzed the features of the HCV-specific CD8 T cell response in eight patients with acute HCV infection, two of whom had a particularly severe illness. Patients with severe hepatitis, but not those with mild disease, showed an extremely vigorous CD8 T cell response narrowly focused on a single epitope (NS3 1073–1081), which cross-reacted with an influenza neuraminidase sequence. Our results suggest that CD8 T cell cross-reactivity influences the severity of the HCV-associated liver pathology and depicts a model of disease induction that may apply to different viral infections.


Abbreviations used: ALT, alanine aminotransferase; HCV, hepatitis C virus; SFC, spot-forming cell.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Private aspects of heterologous immunity
Barbara Rehermann and Eui-Cheol Shin
J. Exp. Med. 2005 201: 667-670. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS